Contraceptive Pills and Retinal Vascularization (PILURET)

  • STATUS
    Recruiting
  • End date
    Mar 13, 2023
  • participants needed
    60
  • sponsor
    Fondation Ophtalmologique Adolphe de Rothschild
Updated on 4 October 2022

Summary

The main hypothesis is the taking of combined 1st and 2nd generation or 3rd and 4th generation oral contraceptives is associated with a change in retinal micro-vascularization compared to the absence of combined oral contraceptive intake.

Women of childbearing age will be recruited during their ophthalmologic consultation at the Rothschild Foundation, an OCT-A will be realized and data relating to their medical and ophthalmologic history and their oestro-progestative contraceptive intake will be collected.

The objective is to find an association between retinal vascular density and combined oral contraceptives intake.

Details
Condition Combined Oral Contraceptives Intake
Treatment OCT-A (Optical Coherence Tomography)
Clinical Study IdentifierNCT03964636
SponsorFondation Ophtalmologique Adolphe de Rothschild
Last Modified on4 October 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

for the control group : No Estro-progestin contraceptive treatment (oral, transdermal) for at least 6 months
for the cases under combined 1st and 2nd generation pills : Estro-progestin contraceptive treatment for at least 6 months
for the cases under combined 3rd and 2th generation pills: Estro-progestin contraceptive treatment for at least 6 months

Exclusion Criteria

Menopausal woman
Ametropia greater than + 3 hyperopia diopters or-3 myopia diopters
Astigmatism greater than 2 dioptres
Smoking patient (cigarette or e-cigarette)
Caffeine intake within 2 hours prior to the OCT-A exam
Any known retinal pathology
Antecedent of deep vein thrombosis or deep arterial thrombosis
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note